Trial intelligence / Profile preview

Contrast Enhanced Ultrasound and Elastography of the Preterm Brain

NCT05694611Phase 3Withdrawn

Sponsor
Turku University Hospital
Start
Jan 2024
Primary completion
Jan 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sulfur hexafluoride in Prematurity (PTB), sponsored by Turku University Hospital. Planned start Jan 2024; status: withdrawn.

02

Drugs

sulfur hexafluoride
03

Conditions

Prematurity (PTB)

Beyond the preview

Go deeper on NCT05694611.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05694611.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call